M. Sánchez-Ronco - Concepedia

Author

M. Sánchez-Ronco

Also Known As

M Sánchez‐Ronco, M. Sanchez-Ronco, M. Sánchez-Ronco, M. Sänchez-Ronco, M.A. Sánchez-Ronco, Marta Auxiliadora Sánchez-Ronco

Publications

699

Citations

H-Index

Concepts

All Affiliations

Institut Català d'Oncologia Universidad de Alcalá Universidad Autónoma de Madrid Hospital Arnau de Vilanova Hospital General Universitario De Valencia

About

M. Sánchez-Ronco is an author at Institut Català d'Oncologia specializing in oncology, medicine, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	301
2	Pathology	4	4	301
3	Cancer Genetics	3	3	246
4	Cancer Therapeutics	1	1	171
5	Genetic Epidemiology	1	1	45

M. Sánchez-Ronco

Publications

673

Citations

H-Index

Page 1

	Year	Citations
Single nucleotide polymorphisms and outcome in docetaxel–cisplatin-treated advanced non-small-cell lung cancer Dolores Isla, Carme Sarries, Rafael Rosell, Annals of Oncology	2004	293
Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients R. de las Peñas, M. Sánchez-Ronco, Vicente Alberola, Annals of Oncology ChromatinGenome InstabilityDna Repair GenesMedicineGenetics	2006	171
Pulsed dye laser vs. photodynamic therapy in the treatment of refractory nail psoriasis: a comparative pilot study M. Fernández‐Guarino, A. Harto, M. Sánchez-Ronco, Journal of the European Academy of Dermatology and Venereology	2009	79
Expression of molecular markers in mediastinal nodes from resected stage I non-small-cell lung cancer (NSCLC): prognostic impact and potential role as markers of occult micrometastases Salvador Benlloch, José M. Galbis, Cristina Alenda, Annals of Oncology Cancer DetectionMolecular MarkersMedicinePathologyCancer Genomics	2008	55
Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine Núria Viñolas, Mariano Provencio, Noemı́ Reguart, Lung Cancer OncologyMedicineGeneticsGenetic EpidemiologyMdr1 Gen Correlates	2010	45
Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies Teresa Morán, Jia Wei, Manuel Cobo, Annals of Oncology OncologyMedicinePathologyBrca1-rap80 Expression CustomizationBiomarker-directed Randomized Trials	2014	30

Page 1